TIME IN THERAPEUTIC RANGE ≥55% VERSUS <55% ON WARFARIN THERAPY OUTCOMES IN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS

被引：1
|
作者：
An, Jaejin [1 ]
Lang, Daniel [1 ]
Fang, Niu [1 ]
Jazdzewski, Kristin [1 ]
Le, Paul [1 ]
Rashid, Nazia [1 ]
Meissner, Brian [1 ]
Mendes, Robert [1 ]
Dills, Diana [1 ]
Ershoff, Dan [1 ]
Borok, Gerald [1 ]
Bruno, Amanda [1 ]
机构：
[1] Kaiser Permanente So Calif, Downey, CA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2014年 / 63卷 / 12期
关键词：
D O I：
10.1016/S0735-1097(14)60359-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1143-114
引用
收藏
页码：A359 / A359
页数：1
相关论文
共 50 条
  • [1] Key Factors That Lower Time in Therapeutic Range of Warfarin in Patients with Non-Valvular Atrial Fibrillation
    Tanaka, T.
    Ihara, M.
    Yamagami, H.
    Toyoda, K.
    Nagatsuka, K.
    CEREBROVASCULAR DISEASES, 2015, 40 : 70 - 70
  • [2] Warfarin in non-valvular atrial fibrillation
    Dalby, A. J.
    Wessels, P.
    Opie, L. H.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2013, 103 (12): : 901 - 904
  • [3] DISCONTINUATION/INTERRUPTION OF WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Wang, J.
    Qiao, Y.
    Spivey, C. A.
    Liu, X.
    Phatak, H.
    Mardekian, J.
    Claflin, A. B.
    Kachroo, S.
    Abdulsatter, Y.
    Parker, R. B.
    VALUE IN HEALTH, 2014, 17 (07) : A763 - A763
  • [4] PROVIDER INTERPRETATION AND UTILIZATION OF TIME IN THERAPEUTIC RANGE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Brunton, Nichole
    Rouzbehani, Jahangir
    Sostin, Oleg
    Wakefield, Dorothy
    Galin, Ira
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2104 - 2104
  • [5] Comparative Effectiveness of Dabigatran versus Warfarin in Patients With Non-Valvular Atrial Fibrillation
    Alonso, Alvaro
    Chen, Lin Y.
    MacLehose, Richard F.
    Lutsey, Pamela L.
    CIRCULATION, 2013, 128 (22)
  • [6] Patients Prescribed Warfarin For Active Non-Valvular Atrial Fibrillation, Their Time In The Therapeutic Range (TTR%) And The Recommendations For Novel Anticoagulant Therapy - A Clinical Audit
    Tansey, P.
    Nugent, M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2018, 187 : S57 - S57
  • [7] Time in the Therapeutic Range During Warfarin Therapy in Japanese Patients With Non-Valvular Atrial Fibrillation - A Multicenter Study of Its Status and Influential Factors -
    Okumura, Ken
    Komatsu, Takashi
    Yamashita, Takeshi
    Okuyama, Yuji
    Harada, Masahiko
    Konta, Yoshiyuki
    Hatayama, Toru
    Horiuchi, Daisuke
    Tsushima, Eiki
    CIRCULATION JOURNAL, 2011, 75 (09) : 2087 - 2094
  • [8] REVIEW OF TIME IN THERAPEUTIC RANGE ON WARFARIN FOR NON-VALVULAR ATRIAL FIBRILLATION (NVAF) IN ADMISSIONS TO A GERIATRIC MEDICINE WARD
    Bhat, M.
    Jegard, J.
    Kaneshamoorthy, M.
    Yeo, J. H.
    O'Brien, A.
    AGE AND AGEING, 2018, 47 : 3 - 3
  • [9] Out-of-range INR values and outcomes among new warfarin patients with non-valvular atrial fibrillation
    Nelson, Winnie W.
    Wang, Li
    Baser, Onur
    Damaraju, Chandrasekharrao V.
    Schein, Jeffrey R.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 53 - 59
  • [10] Out-of-range INR values and outcomes among new warfarin patients with non-valvular atrial fibrillation
    Winnie W. Nelson
    Li Wang
    Onur Baser
    Chandrasekharrao V. Damaraju
    Jeffrey R. Schein
    International Journal of Clinical Pharmacy, 2015, 37 : 53 - 59
12345